Volume 54, Issue 7 pp. 2295-2299
Research Article

Salivary gland epithelial cells: A new source of the immunoregulatory hormone adiponectin

Stergios Katsiougiannis

Stergios Katsiougiannis

University of Athens, Athens, Greece

Search for more papers by this author
Efstathia K. Kapsogeorgou

Efstathia K. Kapsogeorgou

University of Athens, Athens, Greece

Search for more papers by this author
Menelaos N. Manoussakis

Menelaos N. Manoussakis

University of Athens, Athens, Greece

Search for more papers by this author
Fotini N. Skopouli

Corresponding Author

Fotini N. Skopouli

Harokopio University, Athens, Greece

Department of Dietetics and Nutritional Science, Harokopio University, El. Venizelou 70, 17671, Kallithea, Athens, GreeceSearch for more papers by this author
First published: 27 June 2006
Citations: 77

Abstract

Objective

Adiponectin is an adipocytokine that displays insulin-sensitizing and immunoregulatory properties. Adipocyte development in association with fibrosis is frequently detected in primary Sjögren's syndrome lesions, connoting a healing process. The aim of this study was to examine the expression of adiponectin in minor salivary gland biopsy specimens obtained from patients with primary SS and controls.

Methods

The expression of adiponectin in minor salivary gland biopsy specimens and in long-term–cultured non-neoplastic salivary gland epithelial cell (SGEC) lines obtained from patients with primary SS and control subjects was examined, using immunohistochemistry and immunoblotting, respectively. The expression of adiponectin, adiponectin receptor 1 (AdipoR1), and AdipoR2 messenger RNA (mRNA) by SGECs was investigated by reverse transcription–polymerase chain reaction.

Results

Immunohistochemical analysis for adiponectin revealed positive staining of adipocytes from primary SS lesions as well as ductal epithelial cells from both patients with primary SS and controls. All of the SGEC lines tested were shown to express adiponectin, AdipoR1, and AdipoR2 mRNA, whereas adiponectin protein expression was detected by immunoblotting in SGECs from patients with primary SS but not in those from controls. The analysis of concentrated culture supernatants also revealed increased adiponectin expression by SGECs from patients with SS compared with controls.

Conclusion

Our findings provide novel evidence that adiponectin is produced by SGECs. The high constitutive expression of adiponectin by SGECs from patients with primary SS is likely attributable to aberrant activation of these cells. Although the significance of adiponectin expression remains unknown, it is possible that adiponectin functions in an autocrine manner, as suggested by concurrent expression of the relevant receptors.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me